Position in ALKS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$77,290
+$29,166 QoQ
Shares Held
1,475
+8.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#325
of 424 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Kemnay Advisory Services Inc. holds $872,208 across 17 Drug Manufacturers - Specialty & Generic names. ALKS ranks #4 (8.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INDV |
Indivior Pharmaceuticals, Inc.
|
5,829 | $239,163 | |
| 2 | ETON |
Eton Pharmaceuticals, Inc.
|
3,716 | $134,519 | |
| 3 | ANIK |
Anika Therapeutics, Inc.
|
7,958 | $116,425 | |
| 4 | ALKS |
Alkermes plc.
This page
|
1,475 | $77,290 | |
| 5 | LNTH |
Lantheus Holdings, Inc.
|
439 | $48,702 | |
| 6 | LQDA |
Liquidia Corp
|
583 | $46,482 | |
| 7 | HIMS |
Hims & Hers Health, Inc.
|
1,122 | $38,899 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
|
1,620 | $28,042 |
All Filings in ALKS
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $77,290 | 1,475 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $48,124 | 1,361 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $13,206 | 472 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||